Trans American Aquaculture (GRPS) Return on Capital Employed (2024 - 2025)
Trans American Aquaculture (GRPS) reported Return on Capital Employed of 12.77% for Q3 2025, up 5392.0% on a YoY basis from 0.23% in Q3 2024, and down 41.44% quarter-over-quarter from 21.82% in Q2 2025.
Trans American Aquaculture (GRPS) Return on Capital Employed (2024 - 2025) Analysis & Trends
Trans American Aquaculture has reported Return on Capital Employed for 2 years, with the latest figure at 12.77% in Q3 2025.
- For the quarter ending Q3 2025, Return on Capital Employed rose 5392.0% year-over-year to 12.77%; the trailing twelve-month figure through Sep 2025 stood at 12.77% (up 5392.0% YoY), and the FY2024 full-year result was 120.13%, down 8391.0% from the prior year.
- Return on Capital Employed for Q3 2025 stood at 12.77%, down from 21.82% in the prior quarter.
- The five-year high for Return on Capital Employed was 29.11% in Q1 2025, with the low at 131.05% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Trans American Aquaculture | - | - | - | 12.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.77% |
| Jun 30, 2025 | 21.82% |
| Mar 31, 2025 | 29.11% |
| Dec 31, 2024 | -131.05% |
| Sep 30, 2024 | -41.14% |
| Jun 30, 2024 | -42.47% |
| Mar 31, 2024 | -38.51% |